vs

Side-by-side financial comparison of indie Semiconductor, Inc. (INDI) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

indie Semiconductor, Inc. is the larger business by last-quarter revenue ($58.0M vs $44.6M, roughly 1.3× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). indie Semiconductor, Inc. runs the higher net margin — -53.8% vs -90.4%, a 36.6% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -0.0%). indie Semiconductor, Inc. produced more free cash flow last quarter ($-16.1M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 5.3%).

indie Semiconductor is a fabless semiconductor manufacturer focused on designing high-performance mixed-signal and embedded system-on-chip solutions for the automotive industry. Its products support advanced driver assistance systems, in-vehicle infotainment, connected car, and electric vehicle applications, serving global auto OEMs and tier 1 suppliers across major global markets.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

INDI vs PACB — Head-to-Head

Bigger by revenue
INDI
INDI
1.3× larger
INDI
$58.0M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+13.8% gap
PACB
13.8%
-0.0%
INDI
Higher net margin
INDI
INDI
36.6% more per $
INDI
-53.8%
-90.4%
PACB
More free cash flow
INDI
INDI
$3.8M more FCF
INDI
$-16.1M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
5.3%
INDI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INDI
INDI
PACB
PACB
Revenue
$58.0M
$44.6M
Net Profit
$-31.2M
$-40.4M
Gross Margin
37.3%
37.1%
Operating Margin
-58.5%
-92.3%
Net Margin
-53.8%
-90.4%
Revenue YoY
-0.0%
13.8%
Net Profit YoY
9.1%
-1802.7%
EPS (diluted)
$-0.16
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INDI
INDI
PACB
PACB
Q4 25
$58.0M
$44.6M
Q3 25
$53.7M
$38.4M
Q2 25
$51.6M
$39.8M
Q1 25
$54.1M
$37.2M
Q4 24
$58.0M
$39.2M
Q3 24
$54.0M
$40.0M
Q2 24
$52.4M
$36.0M
Q1 24
$52.4M
$38.8M
Net Profit
INDI
INDI
PACB
PACB
Q4 25
$-31.2M
$-40.4M
Q3 25
$-38.3M
$-38.0M
Q2 25
$-39.0M
$-41.9M
Q1 25
$-34.5M
$-426.1M
Q4 24
$-34.4M
$2.4M
Q3 24
$-49.7M
$-60.7M
Q2 24
$-19.2M
$-173.3M
Q1 24
$-31.2M
$-78.2M
Gross Margin
INDI
INDI
PACB
PACB
Q4 25
37.3%
37.1%
Q3 25
40.1%
41.4%
Q2 25
40.6%
36.9%
Q1 25
41.7%
-3.7%
Q4 24
42.6%
25.6%
Q3 24
39.3%
25.0%
Q2 24
42.2%
16.5%
Q1 24
42.5%
29.1%
Operating Margin
INDI
INDI
PACB
PACB
Q4 25
-58.5%
-92.3%
Q3 25
-71.4%
-101.1%
Q2 25
-83.3%
-112.8%
Q1 25
-72.0%
-1154.5%
Q4 24
-58.4%
-390.1%
Q3 24
-92.5%
-160.3%
Q2 24
-70.0%
-488.3%
Q1 24
-94.8%
-209.6%
Net Margin
INDI
INDI
PACB
PACB
Q4 25
-53.8%
-90.4%
Q3 25
-71.3%
-98.9%
Q2 25
-75.6%
-105.4%
Q1 25
-63.9%
-1146.8%
Q4 24
-59.2%
6.0%
Q3 24
-92.1%
-151.9%
Q2 24
-36.6%
-481.3%
Q1 24
-59.6%
-201.4%
EPS (diluted)
INDI
INDI
PACB
PACB
Q4 25
$-0.16
$-0.11
Q3 25
$-0.19
$-0.13
Q2 25
$-0.20
$-0.14
Q1 25
$-0.18
$-1.44
Q4 24
$-0.18
$-0.44
Q3 24
$-0.28
$-0.22
Q2 24
$-0.11
$-0.64
Q1 24
$-0.19
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INDI
INDI
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$145.5M
$279.5M
Total DebtLower is stronger
$353.4M
Stockholders' EquityBook value
$358.0M
$5.3M
Total Assets
$840.8M
$784.1M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INDI
INDI
PACB
PACB
Q4 25
$145.5M
$279.5M
Q3 25
$160.9M
$298.7M
Q2 25
$192.6M
$314.7M
Q1 25
$236.6M
$343.1M
Q4 24
$274.2M
$389.9M
Q3 24
$96.9M
$471.1M
Q2 24
$112.3M
$509.8M
Q1 24
$138.2M
$561.9M
Total Debt
INDI
INDI
PACB
PACB
Q4 25
$353.4M
Q3 25
$353.5M
Q2 25
$352.5M
Q1 25
$379.0M
Q4 24
$381.3M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
INDI
INDI
PACB
PACB
Q4 25
$358.0M
$5.3M
Q3 25
$369.2M
$36.1M
Q2 25
$390.4M
$61.5M
Q1 25
$405.6M
$91.6M
Q4 24
$417.9M
$506.6M
Q3 24
$458.6M
$453.1M
Q2 24
$470.7M
$492.7M
Q1 24
$432.9M
$649.0M
Total Assets
INDI
INDI
PACB
PACB
Q4 25
$840.8M
$784.1M
Q3 25
$855.1M
$803.2M
Q2 25
$867.6M
$825.5M
Q1 25
$909.0M
$860.8M
Q4 24
$941.4M
$1.3B
Q3 24
$797.5M
$1.5B
Q2 24
$797.3M
$1.5B
Q1 24
$803.6M
$1.7B
Debt / Equity
INDI
INDI
PACB
PACB
Q4 25
0.99×
Q3 25
0.96×
Q2 25
0.90×
Q1 25
0.93×
Q4 24
0.91×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INDI
INDI
PACB
PACB
Operating Cash FlowLast quarter
$-14.4M
$-19.1M
Free Cash FlowOCF − Capex
$-16.1M
$-19.9M
FCF MarginFCF / Revenue
-27.8%
-44.6%
Capex IntensityCapex / Revenue
3.0%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-71.4M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INDI
INDI
PACB
PACB
Q4 25
$-14.4M
$-19.1M
Q3 25
$-6.2M
$-18.7M
Q2 25
$-7.6M
$-29.4M
Q1 25
$-29.0M
$-44.1M
Q4 24
$-6.7M
$-30.6M
Q3 24
$-22.8M
$-45.5M
Q2 24
$-19.7M
$-54.3M
Q1 24
$-9.3M
$-75.7M
Free Cash Flow
INDI
INDI
PACB
PACB
Q4 25
$-16.1M
$-19.9M
Q3 25
$-10.3M
$-18.8M
Q2 25
$-13.6M
$-29.9M
Q1 25
$-31.4M
$-45.4M
Q4 24
$-8.6M
$-32.3M
Q3 24
$-29.3M
$-46.3M
Q2 24
$-23.4M
$-55.7M
Q1 24
$-11.7M
$-79.6M
FCF Margin
INDI
INDI
PACB
PACB
Q4 25
-27.8%
-44.6%
Q3 25
-19.2%
-48.9%
Q2 25
-26.4%
-75.3%
Q1 25
-58.0%
-122.3%
Q4 24
-14.8%
-82.3%
Q3 24
-54.3%
-115.7%
Q2 24
-44.7%
-154.8%
Q1 24
-22.3%
-205.0%
Capex Intensity
INDI
INDI
PACB
PACB
Q4 25
3.0%
1.9%
Q3 25
7.8%
0.2%
Q2 25
11.6%
1.4%
Q1 25
4.4%
3.7%
Q4 24
3.2%
4.1%
Q3 24
12.1%
2.0%
Q2 24
7.0%
4.1%
Q1 24
4.4%
10.0%
Cash Conversion
INDI
INDI
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INDI
INDI

Products$55.7M96%
Services$2.3M4%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons